Gold Spinout & Premium Buyback: $180M Deal Funds Future? | Michelle DeCecco – Lithium Chile

In this interview, Michelle DeCecco, VP & COO of Lithium Chile (TSXV: LITH), discusses their $180M USD sale of the Arizaro project in Argentina, which boasts a pre-tax $3.8 billion NPV based on a prefeasibility study.

Dececco addresses Canada’s restrictions on Chinese mining investment, even for overseas assets. She explains the company’s rebranding to “Charge Lithium” and their Kipasa project partnership with Aramet in Chile.

Despite an 80% drop in lithium prices, Dececco remains confident in quality assets. She details plans to return value to shareholders through premium share buybacks while maintaining exposure to 11 lithium properties.


Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security. The Deep Dive and its affiliates hold no licenses.

Video Articles

Why Silver’s Next Move May Be Built on a Much Stronger Base | Mani Alkhafaji – First Majestic Silver

Guanajuato Silver Q1 Earnings: They Finally Post Positive Net Income

We’re in a New Era of Gold Price Discovery | Ryan King – Equinox Gold

Recommended

Canadian Gold Maps Out 2026 Drill Plans Across Three Québec Projects

Mercado Minerals Drills 1,120 g/t Silver Equivalent Over 1.20 Metres At Copalito

Related News

US Cannabis: Public Companies Are Only The Tip Of The Iceberg – The Daily Dive feat Emily Paxhia

Today on the Daily Dive, we sit down with Emily Paxhia, whom is co-founder and...

Thursday, March 11, 2021, 01:30:00 PM

Why Is Silver Trading Below $18? – The Daily Dive

Joining SmallCapSteve today is Jeffrey Christian, Managing Partner at CPM Group. Jeffrey sits with us...

Friday, July 15, 2022, 01:30:00 PM

Amir Adnani: Uranium Supply Has 60 Million Pounds Deficit – The Daily Dive

On this Daily Dive episode, Cassandra has a deep discussion on Uranium with Amir Adnani,...

Thursday, October 7, 2021, 01:30:00 PM

A Medical Breakthrough the Market Overlooked | David Elsley – Cardiol Therapeutics

In this interview David Elsley, CEO of Cardiol Therapeutics (NASDAQ: CRDL) (TSXV: CRDL), shares some...
Monday, August 18, 2025, 03:53:00 PM

Gareth Soloway: Small Caps To Stay Hot – The Daily Dive

Starting off the week on The Daily Dive is that of Gareth Soloway of InTheMoneyStocks....

Monday, February 1, 2021, 01:30:00 PM